A Study of Letrozole in the Treatment of Endometrial Cancer

NCT00333086 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent and Metastatic Endometrial Cancer

Interventions

DRUG: Letrozole

Sponsor

Novartis Pharmaceuticals

Collaborators

[object Object]